COLONYVAQ

· Biogenea Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COLONYVAQ, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer [EARLY_Phase 1]

See pricing